Cost-Effectiveness of Digital Breast Tomosynthesis vs. Abbreviated Breast MRI for Screening Women with Intermediate Risk of Breast Cancer-How Low-Cost Must MRI Be?
Fabian TollensPascal A T BaltzerMatthias DietzelJohannes RübenthalerMatthias Frank FroelichClemens G KaiserPublished in: Cancers (2021)
In comparison to DBT, AB-MRI can be considered cost-effective up to a price per examination of $593 in screening patients at intermediate risk of breast cancer.